Original Article: Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer (phase 3 RASolute 302 trial) https://t.co/y4G27hfORg
#ASCO26 | @ASCO
The best treatment for heart failure? Preventing it. New ESC scientific statement brings together HFA, EAPC, ACNAP & the Council on Hypertension to define the future of heart failure prevention. Read more in #EHJ.
https://t.co/PnoCKxUDbW
#HF#cardiotwitter@ESC_Journals@escardio
How durable is the blood pressure-lowering effect of renal denervation?
In this pooled analysis of 2,137 patients from the SPYRAL Clinical Program, radiofrequency renal denervation was associated with sustained reductions in office and ambulatory blood pressure through 3 years, with nearly 90% of patients experiencing a clinical benefit and few adverse events.
#Hypertension #RenalDenervation #RDN
https://t.co/aFC7h80NDk
@Kandzari@markus_schlaich@FelixMahfoud
Emergentologia; veo un problema en vías de agravarse. LA NACION - Residencias: las especialidades más y menos solicitadas por los médicos que compiten en el examen nacional - https://t.co/HW5tDRUH0r
🔥 #EuroPCR 2026 Major Late-Breaking Trials🔥:
Long-term mortality following PCI with DES versus CABG for left main disease
An individual participant data meta-analysis of the SYNTAX, PRECOMBAT, NOBLE and EXCEL trials presented by Brian Bergmark showed no significant difference in all-cause mortality between DES PCI and CABG over 10-year follow-up in patients with left main coronary artery disease suitable for revascularisation.
Read the press release here ➡️ https://t.co/rPxXxuumpC
#LeftMain #PCI #CABG #CoronaryArteryDisease #InterventionalCardiology #ClinicalTrials
@PCRonline
Finally out! Thank you to all the participating centers and operators!!
Balloon-Assisted Translocation of the Mitral Anterior Leaflet to Prevent Outflow Tract Obstruction During TMVR: BATMAN-Registry | JACC: Cardiovascular Interventions https://t.co/8oF6aF3VyI
In the ICARE OFDI trial (simultaneous publication with presentation at #EuroPCR), intravascular lithotripsy (IVL) was non-inferior to rotational atherectomy for preparation of moderate-to-severe calcified coronary lesions before PCI. MSA was similar (6.0 vs 5.9 mm²), with comparable stent expansion, safety, and 12-month TLF. IVL showed less major strut malapposition. https://t.co/eJEB5TWtcV
The European Valve Durability TAVI Registry highlighted the long-term performance of TAVI. The incidence of moderate or severe structural valve deterioration (SVD) during long-term follow-up was relatively low, with severe SVD being even rarer than moderate SVD. SVD occurred more frequently in patients treated with older-generation intra-annular valves and in those with small-sized valves.
https://t.co/nJhS0ng7rI
🚨 SER MÉDICO PUEDE ENVEJECERTE 6 VECES MÁS RÁPIDO
Durante la residencia:
• −143 pares de bases en telómeros en 1 año
• ≈6x más envejecimiento celular del normal
• Más horas trabajadas = más acortamiento
💡 No es solo burnout: es daño biológico
In the randomized KISS trial of non-LM bifurcations, a conservative strategy without systematic side branch (SB) intervention was noninferior to a systematic SB intervention regarding periprocedural myocardial infarction & myocardial injury. https://t.co/vKpEix9Tjr #JACCINT#cvMI
Yo concuerdo q la evaluación diagnóstica de la enfermedad coronaria, al igual q pasó con la patología aórtica, será por Tomografía; y por cateterismo se harán sólo los procedimientos terapéuticos. (Lo dije ayer en @radiomitre